Drug details

Yonsa (abiraterone acetate tablets)

type of Antineoplastics, Antiandrogen, Antiandrogens

Yonsa (abiraterone acetate) is a CYP17 inhibitor indicated in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).

The drug is often used to treat Prostate cancer .

This drug may have the following side effects:

• shortness of breath,
• vomiting,
• diarrhea,
• fatigue,
• cough,
• high blood pressure (hypertension),
• bruising
• joint swelling or discomfort,
• edema,
• hot flush,
• urinary tract infection (UTI), and

The following drugs are related to Yonsa, either as a replacement or used together:

• Camcevi (leuprolide mesylate injectable emulsion)
• Posluma (flotufolastat f 18 injection)
• Locametz (kit for the preparation of gallium ga 68 aozetotide injection)
• Pluvicto (lutetium lu 177 vipivotide tetraxetan)